Metabolism of amino acids in cancer

Z Wei, X Liu, C Cheng, W Yu, P Yi - Frontiers in cell and …, 2021 - frontiersin.org
Metabolic reprogramming has been widely recognized as a hallmark of malignancy. The
uptake and metabolism of amino acids are aberrantly upregulated in many cancers that …

The metabolic signature of macrophage responses

A Viola, F Munari, R Sánchez-Rodríguez… - Frontiers in …, 2019 - frontiersin.org
Macrophages are a heterogeneous population of immune cells playing several and diverse
functions in homeostatic and immune responses. The broad spectrum of macrophage …

Cellular senescence: aging, cancer, and injury

A Calcinotto, J Kohli, E Zagato… - Physiological …, 2019 - journals.physiology.org
Cellular senescence is a permanent state of cell cycle arrest that occurs in proliferating cells
subjected to different stresses. Senescence is, therefore, a cellular defense mechanism that …

Mechanisms of resistance to immune checkpoint inhibitors

RW Jenkins, DA Barbie, KT Flaherty - British journal of cancer, 2018 - nature.com
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have shown
unprecedented clinical activity in several types of cancer and are rapidly transforming the …

Nerves in cancer

AH Zahalka, PS Frenette - Nature Reviews Cancer, 2020 - nature.com
The contribution of nerves to the pathogenesis of malignancies has emerged as an
important component of the tumour microenvironment. Recent studies have shown that …

Arginine-dependent immune responses

AA Martí i Líndez, W Reith - Cellular and Molecular Life Sciences, 2021 - Springer
A growing body of evidence indicates that, over the course of evolution of the immune
system, arginine has been selected as a node for the regulation of immune responses. An …

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Y Wang, KCC Johnson, ME Gatti-Mays, Z Li - Journal of hematology & …, 2022 - Springer
Immune checkpoint inhibitors targeting programmed cell death protein 1, programmed death-
ligand 1, and cytotoxic T-lymphocyte-associated protein 4 provide deep and durable …

Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno …

S Hendry, R Salgado, T Gevaert… - Advances in anatomic …, 2017 - journals.lww.com
Assessment of the immune response to tumors is growing in importance as the prognostic
implications of this response are increasingly recognized, and as immunotherapies are …

Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naive …

TM Beer, ED Kwon, CG Drake, K Fizazi… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Ipilimumab increases antitumor T-cell responses by binding to cytotoxic T-
lymphocyte antigen 4. We evaluated treatment with ipilimumab in asymptomatic or minimally …

How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer

J Stultz, L Fong - Prostate cancer and prostatic diseases, 2021 - nature.com
Background Advanced prostate cancer remains one of the most common and deadly
cancers, despite advances in treatment options. Immunotherapy has provided little benefit to …